Nanae Aritaka

1.6k total citations · 1 hit paper
14 papers, 1.2k citations indexed

About

Nanae Aritaka is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Nanae Aritaka has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Nanae Aritaka's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Nanae Aritaka is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Nanae Aritaka collaborates with scholars based in Japan. Nanae Aritaka's co-authors include Keiichi Hiramatsu, Hideaki Hanaki, Satoshi Hori, Yasuyuki Hosoda, Yoshinosuke Fukuchi, Intetsu Kobayashi, Shiori Kawasaki, Yasushi Isobe, Longzhu Cui and Norio Komatsu and has published in prestigious journals such as The Lancet, Antimicrobial Agents and Chemotherapy and Journal of Clinical Pathology.

In The Last Decade

Nanae Aritaka

14 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1997 1.0k citations Keiichi Hiramatsu, Nanae Aritaka et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanae Aritaka Japan	7	919	535	520	163	158	14	1.2k
Venkata G. Meka United States	8	702 0.8×	353 0.7×	406 0.8×	167 1.0×	145 0.9×	8	872
Werner W. Wilke United States	17	329 0.4×	308 0.6×	249 0.5×	176 1.1×	285 1.8×	29	1.0k
Wataru Higuchi Japan	23	1.2k 1.3×	522 1.0×	857 1.6×	58 0.4×	210 1.3×	58	1.5k
Christopher P. Montgomery United States	19	943 1.0×	235 0.4×	674 1.3×	81 0.5×	139 0.9×	35	1.4k
Patrizia Posteraro Italy	18	478 0.5×	253 0.5×	264 0.5×	47 0.3×	408 2.6×	34	1.0k
Gayathri Arakere India	20	487 0.5×	168 0.3×	498 1.0×	57 0.3×	217 1.4×	31	954
Adam Waalkes United States	17	239 0.3×	95 0.2×	379 0.7×	161 1.0×	75 0.5×	38	759
Jong Hee Shin South Korea	21	699 0.8×	107 0.2×	194 0.4×	161 1.0×	603 3.8×	71	1.2k
Akihito Nishiyama Japan	18	636 0.7×	216 0.4×	473 0.9×	31 0.2×	241 1.5×	57	957
Elena Tonin Italy	17	265 0.3×	103 0.2×	368 0.7×	194 1.2×	111 0.7×	33	838

Countries citing papers authored by Nanae Aritaka

Since Specialization

Citations

This map shows the geographic impact of Nanae Aritaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanae Aritaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanae Aritaka more than expected).

Fields of papers citing papers by Nanae Aritaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanae Aritaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanae Aritaka. The network helps show where Nanae Aritaka may publish in the future.

Co-authorship network of co-authors of Nanae Aritaka

This figure shows the co-authorship network connecting the top 25 collaborators of Nanae Aritaka. A scholar is included among the top collaborators of Nanae Aritaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanae Aritaka. Nanae Aritaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kobayashi, Jun, et al.. (2021). COVID-19 control during a humanitarian crisis; the need for emergency response at the Thai-Myanmar border as an alternative channel. Tropical Medicine and Health. 49(1). 33–33. 2 indexed citations

Yasuda, Hajime, Jun Ando, Masaaki Noguchi, et al.. (2019). Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients. International Journal of Hematology. 110(5). 543–549. 12 indexed citations

Aritaka, Nanae, Kanako Ogura, Masaru Hosone, et al.. (2015). Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.. PubMed. 8(6). 7559–64. 1 indexed citations

Noguchi, Masaaki, Michiaki Koike, Nanae Aritaka, et al.. (2014). Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival. International Journal of Hematology. 100(4). 370–378. 4 indexed citations

Katayama, Yuki, Tomomi Hishinuma, Akira Iwamoto, et al.. (2014). “Slow VISA,” a Novel Phenotype of Vancomycin Resistance, Found In Vitro in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3. Antimicrobial Agents and Chemotherapy. 58(9). 5024–5035. 31 indexed citations

Isobe, Yasushi, Nanae Aritaka, Yasuhiro Setoguchi, et al.. (2012). T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma. Journal of Clinical Pathology. 65(3). 278–282. 39 indexed citations

Aritaka, Nanae, Hiroko Nakamura, Hajime Yasuda, et al.. (2012). Attainment of a Stringent Complete Response in Multiple Myeloma with Thalidomide Monotherapy. Internal Medicine. 51(19). 2781–2783. 1 indexed citations

Tabe, Yoko, Nanae Aritaka, Yasushi Isobe, et al.. (2011). Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis. Clinical Chemistry and Laboratory Medicine (CCLM). 49(5). 809–815. 1 indexed citations

Yasuda, Hajime, et al.. (2011). Chronic Myelogenous Leukemia with Mild Basophilia as the Predominant Manifestation at Presentation. Internal Medicine. 50(5). 501–502. 10 indexed citations

10.

Yasuda, Hajime, Jun Ando, Eriko Sato, et al.. (2010). Successful Treatment of Extramedullary Tumors with Low-dose Thalidomide in Patients with Multiple Myeloma. Internal Medicine. 49(23). 2617–2620. 3 indexed citations

11.

Sasaki, M., et al.. (2009). Establishment of a Hairy Cell Leukemia Variant Cell Line, HCLv-07. Acta Haematologica. 121(1). 63–66. 2 indexed citations

12.

Isobe, Yasushi, Nanae Aritaka, Makoto Sasaki, Kazuo Oshimi, & Koichi Sugimoto. (2009). Spontaneous regression of natural killer cell lymphoma. Journal of Clinical Pathology. 62(7). 647–650. 29 indexed citations

13.

Aritaka, Nanae, Hideaki Hanaki, Longzhu Cui, & Keiichi Hiramatsu. (2001). Combination Effect of Vancomycin and β-Lactams against a Staphylococcus aureus Strain, Mu3, with Heterogeneous Resistance to Vancomycin. Antimicrobial Agents and Chemotherapy. 45(4). 1292–1294. 29 indexed citations

14.

Hiramatsu, Keiichi, Nanae Aritaka, Hideaki Hanaki, et al.. (1997). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. The Lancet. 350(9092). 1670–1673. 1040 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact